These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7427601)

  • 1. Phenylbutazone overdosage: abnormal metabolism associated with hepatic and renal damage.
    Prescott LF; Critchley JA; Balali-Mood M
    Br Med J; 1980 Oct; 281(6248):1106-7. PubMed ID: 7427601
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
    Pond SM; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)].
    Spahn H; Mutschler E; Geissler HE; Faust-Tinnefeldt G
    Arzneimittelforschung; 1981; 31(3):499-503. PubMed ID: 6894380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma half-life of phenylbutazone in patients with impaired liver function.
    Hvidberg EF; Andreasen PB; Ranek L
    Clin Pharmacol Ther; 1974 Feb; 15(2):171-7. PubMed ID: 4855829
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of phenylbutazone elimination by its metabolite oxyphenbutazone.
    Jähnchen E; Levy G
    Proc Soc Exp Biol Med; 1972 Dec; 141(3):963-5. PubMed ID: 4645785
    [No Abstract]   [Full Text] [Related]  

  • 6. Individual differences in the plasma half-lives of lipid soluble drugs in man.
    Davies DS; Thorgeirsson SS
    Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():181-90. PubMed ID: 5316400
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxyphenbutazone and phenylbutazone determination in plasma and urine by GLC.
    Bruce RB; Maynard WR; Dunning LK
    J Pharm Sci; 1974 Mar; 63(3):446-8. PubMed ID: 4820382
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of bumadizone, phenylbutazone and oxyphenbutazone in human plasma by high-performance liquid chromatography (author's transl)].
    Spahn H; Mutschler E
    Arzneimittelforschung; 1981; 31(3):495-9. PubMed ID: 6894379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reduction of plasma concentrations of phenylbutazone and oxyphenbutazone in smokers].
    Ollagnier M; Queneau P; Latour JF; Brazier JL; Decousus H; Faucon G
    Therapie; 1982; 37(5):549-56. PubMed ID: 7179323
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug interactions in the horse: effects of chloramphenicol, quinidine, and oxyphenbutazone on phenylbutazone metabolism.
    Tobin T; Blake JW; Valentine R
    Am J Vet Res; 1977 Jan; 38(1):123-7. PubMed ID: 835859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of phenylbutazone and oxyphenbutazone in plasma by high-speed liquid chromatography.
    Pound NJ; Sears RW
    J Pharm Sci; 1975 Feb; 64(2):284-7. PubMed ID: 1127584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of dietary portein on the disposition and metabolism of phenylbutazone in rats.
    Varma DR
    Can J Physiol Pharmacol; 1980 Mar; 58(3):231-6. PubMed ID: 7378926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation of furosemide, phenylbutazone and oxyphenbutazone in plasma by direct injection onto internal surface reversed-phase columns with systematic optimization of selectivity.
    Pinkerton TC; Perry JA; Rateike JD
    J Chromatogr; 1986 Oct; 367(2):412-8. PubMed ID: 3782354
    [No Abstract]   [Full Text] [Related]  

  • 14. GLC determination of plasma concentration of phenylbutazone and its metabolite oxyphenbutazone.
    Midha KK; McGilveray IJ; Charette C
    J Pharm Sci; 1974 Aug; 63(8):1234-9. PubMed ID: 4852201
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of tobacco on the serum levels and pharmacokinetics of phenylbutazone and oxyphenbutazone].
    Queneau P; Ollagnier M; Decousus H; Perpoint B; Brazier JL; Faucon L
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):293-7. PubMed ID: 6879097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoperfusion for phenylbutazone poisoning.
    Berlinger WG; Spector R; Flanigan MJ; Johnson GF; Groh MR
    Ann Intern Med; 1982 Mar; 96(3):334-5. PubMed ID: 7059098
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatic and renal damage with paractamol overdosage.
    Brown RA
    J Clin Pathol; 1968 Nov; 21(6):793. PubMed ID: 5717565
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies of the interaction of phenylbutazone, oxyphenbutazone and methandrostenolone in man.
    Hvidberg EF; Dayton PG; Read JM; Wilson CH
    Proc Soc Exp Biol Med; 1968 Nov; 129(2):438-43. PubMed ID: 5696765
    [No Abstract]   [Full Text] [Related]  

  • 20. Poisoning with equine phenylbutazone in a racetrack worker.
    Newton TA; Rose SR
    Ann Emerg Med; 1991 Feb; 20(2):204-7. PubMed ID: 1996808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.